Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WISDOM: Stepwise Withdrawal of Inhaled Corticosteroids in COPD
NCT00975195Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Feb 2009
- Primary completion
- Jul 2013
- Modality
- Orthosteric Ligands
- Countries
- 23
01
Overview
A Phase 4 trial of fluticasone propionate nasal spray in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Feb 2009; status: completed.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00975195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975195.